Skip to main content
. 2013 Oct 23;6:80. doi: 10.1186/1756-8722-6-80

Figure 1.

Figure 1

Forest plots from a meta-analysis of overall survival (A), disease-free survival (B), bone metastasis-free survival (C), distant metastasis-free survival (D), and fracture-free rate (E) for the adjuvant use of zoledronic acid compared to the control arm.